Bioeksen R&D Technologies
Bioeksen R&D Technologies is a private Istanbul-based biotechnology firm, founded in 2014, that develops molecular diagnostic systems, real-time PCR test kits, and Next-Generation Sequencing services for clinical and research customers.
- Company typePrivate
- Founded2014
- HeadquartersIstanbul
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Bioeksen R&D Technologies does
Bioeksen R&D Technologies is a private, for-profit biotechnology firm headquartered in Istanbul, Turkey, founded in 2014. According to its firmographic profile, the company develops and offers molecular diagnostic systems, real-time PCR test kits, and Next-Generation Sequencing (NGS) services. This positions it within the clinical and research molecular diagnostics value chain, serving customers who require nucleic-acid-based pathogen detection, genetic testing, and sequencing-based analysis.
The company's product surface spans three interrelated layers: instrumentation (molecular diagnostic systems), consumables (real-time PCR test kits), and service revenue (NGS services). This combination suggests an integrated model where the firm both sells physical diagnostic products and performs sequencing work on behalf of clients, typical of small-cap molecular diagnostics boutiques that compete on assay design, turnaround time, and local-market reach. Founded in 2014 and headquartered in Istanbul, Bioeksen operates with a headcount of 11-50 employees, indicating a small, specialist team rather than a scaled commercial platform.
The input data does not disclose pricing models, customer segments, distribution channels, go-to-market strategy, or ownership details. The company's website was inaccessible at the time of capture (presenting only a loader/verification page), which prevented extraction of corporate history, investor information, certifications, or partnerships. Consequently, the business model — specifically how revenue is split between kit sales, instrument placement, and service fees, and whether customers are concentrated in Turkish healthcare providers, research institutes, or international accounts — cannot be characterized from the available evidence.
Bioeksen R&D Technologies firmographics
Firmographics- Name
- Bioeksen R&D Technologies
- Website
- https://bioeksen.com.tr
- Company type
- Private
- Founded year
- 2014
- Headcount range
- 11–50 employees
- Short description
- Bioeksen R&D Technologies is a private Istanbul-based biotechnology firm, founded in 2014, that develops molecular diagnostic systems, real-time PCR test kits, and Next-Generation Sequencing services for clinical and research customers.
- Ownership category
- akta.pro rank
Bioeksen R&D Technologies industry classification
Industry- Product category
- Molecular Diagnostics
- NAICS
- Medical Laboratories (621511), Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Medical Laboratories (8071), Services-Testing Laboratories (8734), In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)
- akta.pro secondary industries
- Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF), Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)
Keywords
Where Bioeksen R&D Technologies is headquartered
LocationHeadquarters
- HQ city
- Istanbul
Markets served
Bioeksen R&D Technologies business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations
Bioeksen R&D Technologies product offering
Product offeringCore offering
Bioeksen R&D Technologies is a biotechnology firm that develops and supplies molecular diagnostic systems, real-time PCR test kits, and Next-Generation Sequencing (NGS) services. The company focuses on R&D-driven molecular biology tools and services used by laboratories and clinical settings for nucleic acid-based detection and analysis.
Differentiator
Problem solved
Functional benefit
Products and services
- Molecular Diagnostic Systems Molecular diagnostic systems designed for nucleic acid-based detection and analysis, used by clinical and research laboratories for diagnostic workflows.
- Real-Time PCR Test Kits Real-time PCR test kits for molecular biology and clinical diagnostics applications, supplied to laboratories conducting nucleic acid amplification testing.
- NGS Services Next-Generation Sequencing services providing sequencing-based analysis to research and clinical customers requiring genomic or transcriptomic data.
Companies that use Bioeksen R&D Technologies
Customer profileIdeal customer profiles1 record
Bioeksen R&D Technologies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Bioeksen R&D Technologies partnerships and signals
Strategic signalRecent moves2 records
Bioeksen R&D Technologies competitors and assessment
Company assessmentBroad incumbents
- Roche Diagnostics: Roche operates cobas PCR systems and a broad molecular diagnostics menu including NGS oncology panels, dwarfing Bioeksen's scale but serving overlapping clinical laboratories and hospital customers.
- Illumina: Illumina dominates NGS sequencing platforms and reagents; while Bioeksen is more likely a customer/partner than direct competitor, Illumina's installed base defines the NGS services market Bioeksen serves.
- Thermo Fisher Scientific: Thermo Fisher offers Applied Biosystems qPCR instruments, Ion Torrent NGS, and diagnostic test kits, competing across both of Bioeksen's core product lines as part of a far broader life-sciences portfolio.
Direct peers
- Qiagen: Qiagen is a global molecular diagnostics and sample-prep provider spanning PCR assays, NGS library prep, and instruments — the most comprehensive direct overlap with Bioeksen's combined PCR/NGS portfolio.
- Bio-Rad Laboratories: Bio-Rad is a global leader in real-time PCR instruments (CFX), diagnostic kits, and droplet digital PCR, directly competing with Bioeksen's PCR kit and instrument offerings across clinical and research customers.
- Anatolia Geneworks: Anatolia Geneworks is a Turkey-based molecular diagnostics and genetic testing company offering PCR kits, DNA/RNA extraction, and genotyping services, making it the closest domestic peer to Bioeksen in both geography and product mix.
Emerging players
- GenMark Diagnostics: GenMark (now part of Roche) developed molecular diagnostic panels on its ePlex platform, illustrating the multiplex molecular diagnostics niche that Bioeksen's PCR kit business targets.
Regional players
- RTA Laboratories: RTA Laboratories is a Turkish molecular diagnostics and genetic testing provider, serving as a regional peer with comparable PCR- and genetic-testing offerings concentrated in the Turkish market.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights4 records
Customer concentration
Bioeksen R&D Technologies social profiles
Digital presenceBioeksen R&D Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bioeksen R&D Technologies leadership team
Management profileNumber of profiles
Bioeksen R&D Technologies funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bioeksen R&D Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bioeksen R&D Technologies
What does Bioeksen R&D Technologies do?
Bioeksen R&D Technologies is a biotechnology firm that develops and supplies molecular diagnostic systems, real-time PCR test kits, and Next-Generation Sequencing (NGS) services. The company focuses on R&D-driven molecular biology tools and services used by laboratories and clinical settings for nucleic acid-based detection and analysis.
When was Bioeksen R&D Technologies founded?
Bioeksen R&D Technologies was founded in 2014. It employs 11 to 50 people.
Where is Bioeksen R&D Technologies based?
Bioeksen R&D Technologies is headquartered in Istanbul.
Who are Bioeksen R&D Technologies's main competitors?
Broad incumbents on record are Roche Diagnostics, Illumina and Thermo Fisher Scientific. Direct peers are Qiagen, Bio-Rad Laboratories and Anatolia Geneworks. GenMark Diagnostics is listed as an emerging player. RTA Laboratories is listed as a regional player.
Does Bioeksen R&D Technologies have an API?
No public API is recorded for Bioeksen R&D Technologies.
What industry is Bioeksen R&D Technologies in?
Bioeksen R&D Technologies's product category is Molecular Diagnostics. Its primary akta.pro industry code is HLAFAMAE, Molecular Diagnostics & Genomics Laboratories, with a secondary code of HLAGANAA, Genomics & Next-Generation Sequencing (NGS) Services. Its NAICS code is 621511 and its SIC code is 8071.